BMS-986179

null · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986179, covering 2023-04-05 to 2023-04-05. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab [Phase 1, Phase 2]

See pricing